Researcher: Big data, networks identify cell signaling pathways in lung cancer

May 22, 2018, University of Montana
The cover of the May 22 issue of Science Signaling features a three-dimensional representation of lung cancer protein modifications produced by the machine learning algorithm, t-SNE. Clusters of modifications are painted the same color. Credit: Science Signaling

A team of scientists led by University of Montana cell biologist Mark Grimes has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.

The paper, published as the cover article of the May 22 issue of Science Signaling, sheds light on how a new class of drugs called HSP90 inhibitors—which are currently in clinical trials—works to fight cancer. It is the first large-scale study to analyze three different kinds of protein modifications simultaneously while also employing new methods that involve mathematical and computational approaches and networks to analyze these data.

The paper is titled "Integration of protein phosphorylation, acetylation, and methylation datasets to outline signaling networks."

Compared to all other cancers, cancer is still the most deadly, despite reductions in recent years due to decreases in cigarette smoking. Lung cancer is expected to kill about 150,000 people in the United States this year, according to the American Cancer Society.

The study began with scientists at Cell Signaling Technology, who collected a large amount of data from . The approach to analyze the data builds on previous work from the Grimes laboratory.

"Proteins modify each other in different ways inside cells to convey signals," Grimes said. "The signals tell cells to divide, differentiate or die. Cancer is many diseases, and many types of cancer are caused by screwed up cell signaling mechanisms. This study defines these signaling pathways with greater precision and integrates pathways that use different protein modifications."

The study looked at 45 different lung cancer cell types and compared their modified proteins to normal lung tissue. To make sense of the large amount of data, sophisticated pattern recognition techniques—including machine-learning algorithms—were used, and patterns in protein modifications were combined with interaction networks to define cell signaling pathways in lung cancer cells.

Grimes' research team includes three UM students and two other UM faculty members: Travis Wheeler from the Department of Computer Science and Ekaterina Smirnova from the Department of Mathematical Sciences. The team also included computational biologist Avi Ma'ayan and his team from Icahn School of Medicine at Mount Sinai, New York; and scientists from Cell Signaling Technology, Danvers, MA led by Michael Comb.

Grimes emphasized that this research is a team effort.

"Progress is made when people with different skills come together to tackle a hard problem," he said. "It was gratifying to involve UM graduate and undergraduate students Lauren Foltz, Jeremiah Gaiser and William Cook, who each contributed uniquely to the project."

Due to the complexity of the information, Grimes offers an analogy to get across the main points of the paper:

"Cells are bags of proteins and other components like DNA. Different components are contained within intracellular compartments walled off by membranes. Imagine the cell as a house, and people within are proteins. Different groups of people spend more time in different places, depending on their jobs in the house. In the cell, proteins modify one another by attaching phosphate, methyl and acetyl groups, which is akin to people attaching different balloons to one another. The balloons attract particular people to come together, depending on which balloon is carried. This sends a signal to the people attracted to the balloon holder to move within the house and engage in some activity. For example, someone hands you a red balloon and you assemble a group of cooks to go to the kitchen and make a meal.

"We can represent the way people interact with one another in the house as a network. Most of the people in the house interact with many other people over the course of a year, so the network of interactions looks like a hairball, which is not very informative. We want to unravel the hairball, picking out pathways through the network that depend on who gets the balloons. This is where mathematical tricks and machine-learning algorithms come into play. These pattern-recognition techniques help us to identify clusters of people who get different balloons—clusters of proteins that become modified—in similar ways. We then look at interactions only among those clusters of people. In other words, the clusters are used to filter the interactions. This cluster-filtered network is a much simpler network, and informs us about signaling pathways specific to lung cancer ."

Grimes continues, "To take the analogy further, a tumor is like a house that turns itself into a large factory that uses up the community's energy resources in a residential zone of single-family dwellings. Researchers are like detectives who examine the people holding three different types of balloons simultaneously in many different factories (tumor cell types). The detectives use this information to trace pathways of communications that are common when a house breaks the community rules.

"The cluster-filtered identifies the bad guys and their collaborators so we have a better idea who should be arrested by law enforcement to stop the house from expanding in the wrong neighborhood," Grimes said. "In other words, this study gives us a better idea which proteins to target with drugs to arrest different types of lung ."

Explore further: Mathematical modeling offers new way to understand variable responses to targeted therapy

More information: Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks, Sci. Signal.  22 May 2018: Vol. 11, Issue 531, eaaq1087 , DOI: 10.1126/scisignal.aaq1087

Related Stories

Mathematical modeling offers new way to understand variable responses to targeted therapy

April 3, 2018
Cancer therapies that target a specific protein have improved outcomes for patients. However, many patients eventually develop resistance to these targeted therapies and their cancer comes back. It is believed that differences ...

Ras protein's role in spreading cancer

February 18, 2018
Protein systems, such as Ras, make up the complex signaling pathways that control whether a cell divides or, in some cases, becomes cancerous and metastasizes into other regions of the body. For example, 98 percent of pancreatic ...

Researchers identify possible new target in fight against lung cancer

September 12, 2017
Researchers at Boston University School of Medicine (BUSM) have identified a molecule called miR-124 in non-small cell lung cancer cells that plays a regulatory role in the cancer cells' fate—determining whether or not ...

Before a cure, a crusade to stop lung cancer from spreading

November 11, 2016
The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016.

Team develops technology to find optimum drug target for cancer

December 18, 2017
A KAIST research team led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering developed technology to find the optimum drug targets for specific types of cancer cells. The team used systems biology ...

Recommended for you

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

Repurposing FDA-approved drugs can help fight back breast cancer

November 16, 2018
Screening Food and Drug Administration (FDA)-approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in ...

Traditional chemotherapy superior to new alternative for oropharyngeal cancers

November 16, 2018
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...

New 'SLICE' tool can massively expand immune system's cancer-fighting repertoire

November 15, 2018
Immunotherapy can cure some cancers that until fairly recently were considered fatal. In addition to developing drugs that boost the immune system's cancer-fighting abilities, scientists are becoming expert at manipulating ...

Anti-malaria drugs have shown promise in treating cancer, and now researchers know why

November 15, 2018
Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers from the Abramson ...

Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds

November 15, 2018
A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.